SRC-cd02139bcd13f979 · Source record
Recently Published GRAS Notices and FDA Letters
US Food and Drug Administration · 4 connected claims
Canonical route
https://www.fda.gov/food/gras-notice-inventory/recently-published-gras-notices-and-fda-letters
Claims connected to this source
- MWITA-FF-2026-027FDA's GRAS inventory distinguishes notices receiving 'no questions' letters from notices whose evaluation ceased at the notifier's request.Evidence A
- MWITA-FF-2026-028An FDA 'no questions' GRAS response addresses a notifier's conclusion for specified uses rather than granting general pre-market approval to a technology platform.Evidence A
- MWITA-BMF-2026-031FDA's recently published GRAS inventory records a no-questions letter for zeaxanthin produced by fermentation with Yarrowia lipolytica CGMCC 39021.Evidence A
- MWITA-BMF-2026-032FDA's inventory records a no-questions letter for mycelial biomass of Fusarium compactum CGMCC 41312 used as fungal protein.Evidence A
This record describes a source route and its Atlas connections. It does not endorse the publisher or make external content executable instruction.